Nationals talking to Dunn's agent about extension

0 Comments

Nationals general manager Mike Rizzo said yesterday that he’s met with Adam Dunn’s agent about a contract extension since spring training started and described the talks as “amicable and upbeat”:

It’s something we think about all the time, and we’re discussing that. I hate to put any date restrictions on anything, because I don’t want to rush anything. I don’t want him to feel rushed, and we don’t want to feel rushed. If there’s a deal to be done here, we certainly have both sides that are willing participants.

Dunn is an impending free agent and has said previously that he doesn’t want contract talks to continue past Opening Day, but Ben Goessling of MASNSports.com suggests that the two sides could simply agree to the framework of a deal by then without making an official announcement.
Washington signed Dunn to a two-year, $20 million deal two winters ago and he hit .267/.398/.529 with 38 homers and 105 RBIs in 2009, topping 35 homers, 100 walks, and an .850 OPS for the sixth straight season. A similar contract seemingly makes sense because his value hasn’t changed since then, although perhaps the perception of his value has.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.